Fairvalue-Calculator Fairvalue-Calculator

Target Healthcare REIT PLC (THRL) Fair Value & Analysis

Real Estate · GB · Market cap 657M GBX

Pricep1.04
Fair Valuep1.31
Upside+26.0%
Quality95/100
Evidence: High Range p0.9000 – p1.72

Analysis

Target Healthcare REIT PLC (THRL) currently trades at p1.04, while our model-based Fair Value estimate is p1.31 — implying the stock looks roughly 26.0% undervalued today. We read business quality at 95/100 (high quality), in the Real Estate sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Target Healthcare REIT PLC is an externally managed FTSE 250 Real Estate Investment Trust. The firm provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes. The Group portfolio at 31 December 2025 comprised 86 assets let to 32 tenants with a total value of 894.6 million pounds. The Group invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors. Target Healthcare REIT PLC was incorporated in 2013 in United Kingdom.

Open the full interactive analysis →

Similar stocks

Welltower Inc (WELL) -77% Ventas, Inc (VTR) -79% Omega Healthcare Investors, Inc (OHI) -11% Healthpeak Properties, Inc (DOC) -82% American Healthcare REIT, Inc (AHR) -78% CareTrust REIT, Inc (CTRE) -41%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.